Recap: RBC Bearings Q3 Earnings

  RBC Bearings (NASDAQ:ROLL) reported its Q3 earnings results on Thursday, February 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

 

RBC Bearings (NASDAQ:ROLL) reported its Q3 earnings results on Thursday, February 10, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Check out this: Insiders Buy Over $43M Of 4 Stocks

Earnings

RBC Bearings beat estimated earnings by 22.81%, reporting an EPS of $0.7 versus an estimate of $0.57.

Revenue was up $121.09 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.14, which was followed by a 1.38% drop in the share price the next day.

Here’s a look at RBC Bearings’s past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 1.03 0.99 1.05 0.85
EPS Actual 0.89 1.04 1.08 0.90
Revenue Estimate 159.64M 158.77M 158.83M 141.79M
Revenue Actual 160.90M 156.21M 160.29M 145.86M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Sarepta Therapeutics, GenEdit Share Progress On Research Collaboration And Announce Agreement To Develop Gene Editing Therapeutics For Neuromuscular Diseases; GenEdit May Receive Up To $57M In Near-term Payments And Is Also Eligible For Future Mileston…

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, and GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxyTM polymer nanoparticle platform for

SRPT

Read More

Workiva’s Earnings Outlook

Workiva (NYSE:WK) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts estimate that Workiva will likely report an Earnings Per Share (EPS) of $-0.11

WK